Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Depreciation & Amortization (CF) (2018 - 2025)

TELA Bio (TELA) has 8 years of Depreciation & Amortization (CF) data on record, last reported at $153000.0 in Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) fell 8.93% year-over-year to $153000.0; the TTM value through Sep 2025 reached $671000.0, up 34.47%, while the annual FY2024 figure was $632000.0, 58.0% up from the prior year.
  • Depreciation & Amortization (CF) reached $153000.0 in Q3 2025 per TELA's latest filing, down from $175000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $175000.0 in Q2 2025 and bottomed at $30000.0 in Q4 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $111315.8, with a median of $119000.0 recorded in 2023.
  • Peak YoY movement for Depreciation & Amortization (CF): plummeted 66.07% in 2023, then surged 350.0% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $30000.0 in 2021, then soared by 273.33% to $112000.0 in 2022, then tumbled by 66.07% to $38000.0 in 2023, then soared by 350.0% to $171000.0 in 2024, then dropped by 10.53% to $153000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $153000.0 in Q3 2025, $175000.0 in Q2 2025, and $172000.0 in Q1 2025.